Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAccepted Article

Doppler signal and bone erosions at the enthesis are independently associated with ultrasound joint erosive damage in psoriatic arthritis

Gianluca Smerilli, Edoardo Cipolletta, Giulia Maria Destro Castaniti, Andrea Di Matteo, Marco Di Carlo, Erica Moscioni, Francesca Francioso, Riccardo Mashadi Mirza, Walter Grassi and Emilio Filippucci
The Journal of Rheumatology February 2022, jrheum.210974; DOI: https://doi.org/10.3899/jrheum.210974
Gianluca Smerilli
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edoardo Cipolletta
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Maria Destro Castaniti
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Di Matteo
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Di Carlo
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Moscioni
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Francioso
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riccardo Mashadi Mirza
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Grassi
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilio Filippucci
Marche Polytechnic University, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy; University of Palermo, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, "P. Giaccone" Hospital, Palermo, Italy; Radiology Department, A.O. Ospedali Riuniti Marche Nord, Pesaro, Italy. Funding: No specific funding was received from any bodies in the public, commercial or not-forprofit sectors to carry out the work described in this article. Conflicts of interests: E.F. has received speaking fees from AbbVie, Amgen, Bristol -Myers Squibb, Janssen- Cilag, Lilly, Novartis, Pfizer, Roche and Union Chimique Belge Pharma. W.G. has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and Union Chimique Belge Pharma. All other authors disclose no conflict of interest. Corresponding author: Gianluca Smerilli, MD, Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Ancona, Italy, Via Aldo Moro 25, 60035 Jesi, Ancona, Italy. E-mail address: smerilli.gianluca@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective To explore the association of the OMERACT ultrasound (US) entheseal abnormalities with the presence of US joint bone erosions in psoriatic arthritis (PsA).

Methods Consecutive PsA patients were included in this cross-sectional study. Demographic and clinical parameters were collected. A bilateral US assessment was carried out at the following entheses: plantar fascia, quadriceps, patellar (proximal and distal) and Achilles tendons. The following US entheseal abnormalities were registered: hypoechogenicity, thickening, Doppler signal <2mm from the bony cortex, calcification/enthesophyte, bone erosion. The presence of US joint bone erosions was investigated at the 2nd and 5th metacarpophalangeal (MCP) joints, ulnar head and 5th metatarsophalangeal (MTP) joint, bilaterally, as well as at the level of the most inflamed joint on physical examination. Multiple linear regression analysis was performed to identify clinical and/or US variables associated with US-detected joint bone erosions.

Results A total of 104 PsA patients were enrolled. At least one joint bone erosion was found in 47/104 patients (45.2%). Bone erosions were most frequently detected at 5th MTP joint level (42/208 joints, 20.2 %; 32/104 patients, 30.8%). In the multivariate model, only PD signal at the enthesis (P<0.001, standardized β=0.51), bone erosions at the enthesis (P=0.02, standardized β=0.2), PsA disease duration (P=0.04, standardized β=0.17) and greyscale joint synovitis (P=0.03, standardized β=0.42) were associated with US-detected joint bone erosions.

Conclusion PD signal and bone erosions at the enthesis represent sonographic biomarkers of a more severe subset of PsA in terms of US-detected joint erosive damage.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 49, Issue 8
1 Aug 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Doppler signal and bone erosions at the enthesis are independently associated with ultrasound joint erosive damage in psoriatic arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted manuscript
Doppler signal and bone erosions at the enthesis are independently associated with ultrasound joint erosive damage in psoriatic arthritis
Gianluca Smerilli, Edoardo Cipolletta, Giulia Maria Destro Castaniti, Andrea Di Matteo, Marco Di Carlo, Erica Moscioni, Francesca Francioso, Riccardo Mashadi Mirza, Walter Grassi, Emilio Filippucci
The Journal of Rheumatology Feb 2022, jrheum.210974; DOI: 10.3899/jrheum.210974

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Accepted manuscript
Doppler signal and bone erosions at the enthesis are independently associated with ultrasound joint erosive damage in psoriatic arthritis
Gianluca Smerilli, Edoardo Cipolletta, Giulia Maria Destro Castaniti, Andrea Di Matteo, Marco Di Carlo, Erica Moscioni, Francesca Francioso, Riccardo Mashadi Mirza, Walter Grassi, Emilio Filippucci
The Journal of Rheumatology Feb 2022, jrheum.210974; DOI: 10.3899/jrheum.210974
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis
  • The sensitivity to change of the ASAS Health Index in an observational real-life cohort study
  • Pediatric to Adult Transition Literature: Scoping Review and Rheumatology Research Prioritization Survey Results
Show more Accepted Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire